Patent Assignment
Reel/Frame 068821/0568
Second Lien Intellectual Property Security Agreement
Recorded: 2024-09-03
Pages: 9
Assignors
BAUSCH HEALTH IRELAND LIMITED
Executed: 2024-08-28
SALIX PHARMACEUTICALS, INC.
Executed: 2024-08-28
Assignee
THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
240 GREENWICH STREET, NEW YORK, NEW YORK, 10286
Covered Properties
(5)
Methods for Treating Irritable Bowel Syndrome (Ibs)
Application:
18/628,353 →
Publication:
US 2024/0285591
Methods for Treating Irritable Bowel Syndrome (Ibs)
Application:
18/628,366 →
Publication:
US 2024/0342142
Topical Compositions
Topical Compositions
Methods of Treating Hepatic Encephalopathy
Application:
18/667,886 →
Publication:
US 2024/0299368
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Intellectual Property Security Agreement
Sep 3, 2024
From: BAUSCH HEALTH IRELAND LIMITED; SALIX PHARMACEUTICALS, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 068821/0550 →
Intellectual Property Security Agreement
Sep 3, 2024
From: BAUSCH HEALTH IRELAND LIMITED; SALIX PHARMACEUTICALS, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 068821/0559 →
Assignment of Assignor's Interest
Sep 30, 2024
From: BHATT, VARSHA; PILLAI, RADHAKRISHNAN; ANGEL, ARTURO
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 069076/0260 →
Release of Security Interest
Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →
U.S. Patent Security Agreement
Nov 25, 2025
From: BAUSCH HEALTH IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 073715/0375 →